Cargando…
CRISPR/Cas9-based liver-derived reporter cells for screening of mPGES-1 inhibitors
mPGES-1 is a terminal rate-limiting enzyme responsible for inflammation-induced PGE2 production. The inhibition of mPGES-1 has been considered as a safe and effective target for the treatment of inflammation and cancer. However, a specific, efficient, and simple method for high-throughput screening...
Autores principales: | Chen, Zhanfei, Cai, Xiaoling, Li, Man, Yan, LinLin, Wu, Luxi, Wang, Xiaoqian, Tang, Nanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427568/ https://www.ncbi.nlm.nih.gov/pubmed/30879343 http://dx.doi.org/10.1080/14756366.2019.1587416 |
Ejemplares similares
-
Downregulation of mPGES-1 Expression via EGR1 Plays an Important Role in Inhibition of Caffeine on PGE(2) Synthesis of HBx(+) Hepatocytes
por: Ma, Yan, et al.
Publicado: (2015) -
Analgesic effects of a highly selective mPGES-1 inhibitor
por: Stewart, Madeline J., et al.
Publicado: (2023) -
Discovery of novel, non-acidic mPGES-1 inhibitors by virtual screening with a multistep protocol
por: Noha, Stefan M., et al.
Publicado: (2015) -
Arzanol, a Potent mPGES-1 Inhibitor: Novel Anti-Inflammatory Agent
por: Kothavade, Pankaj S., et al.
Publicado: (2013) -
Targeting mPGES-1 as a New Strategy against Neuroblastoma
por: Comunanza, Valentina
Publicado: (2018)